TFF Pharmaceuticals Partners with Emory University and BARDA to Develop a Dry Powder Inhaled mRNA-based Treatment for Influenza and COVID

Partnership funded by BARDA and other US government agencies

TFF formulation may provide flexibility of delivery and improve storage and distribution conditions

Read more at globenewswire.com